Approval · Notice of Compliance 1313 · 2000
CELLCEPT: Notice of Compliance 1313
Issued May 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1313
- Date
- May 9, 2000
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Immunosuppressent agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELLCEPT | 02242145 | Marketed |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 200 MG per ML